Edward Miller Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Edward Miller.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Edward Miller. Edward Miller is SVP, Chief Compliance Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and General Counsel in Allovir, Inc. ($ALVR).
Latest Insider Trading Transactions of Edward Miller
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2021 | ALVR | Allovir, Inc. | Miller Edward | General Counsel | Sell | S | 39.14 | 2,200 | 86,108 | 192,811 | 195 K to 192.8 K (-1.13 %) |
Mar 03 2021 | ALVR | Allovir, Inc. | Miller Edward | General Counsel | Sell | S | 38.58 | 3,800 | 146,592 | 195,011 | 198.8 K to 195 K (-1.91 %) |
Jan 21 2021 | ALVR | Allovir, Inc. | Miller Edward | General Counsel | Option Exercise | A | 42.15 | 52,000 | 2,191,800 | 52,000 | |
Jan 21 2021 | ALVR | Allovir, Inc. | Miller Edward | General Counsel | Grant | A | 0.00 | 28,000 | 0 | 194,051 | 166.1 K to 194.1 K (+16.86 %) |
Jan 21 2021 | ALVR | Allovir, Inc. | Miller Edward | General Counsel | Gift | G | 0.00 | 41,514 | 0 | 198,811 | 157.3 K to 198.8 K (+26.39 %) |
Jan 21 2021 | ALVR | Allovir, Inc. | Miller Edward | General Counsel | Gift | G | 0.00 | 41,514 | 0 | 166,051 | 207.6 K to 166.1 K (-20.00 %) |
Aug 06 2020 | ALVR | Allovir, Inc. | Miller Edward | General Counsel | Option Exercise | C | 0.00 | 48,819 | 0 | 0 | |
Aug 06 2020 | ALVR | Allovir, Inc. | Miller Edward | General Counsel | Buy | C | 0.00 | 32,759 | 0 | 32,759 | 0 to 32.8 K |
Jul 31 2020 | ALVR | Allovir, Inc. | Miller Edward | General Counsel | Option Exercise | A | 17.00 | 200,600 | 3,410,200 | 200,600 | |
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Option Exercise | A | 131.25 | 8,700 | 1,141,875 | 8,700 | |
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Grant | A | 0.00 | 4,400 | 0 | 19,284 | 14.9 K to 19.3 K (+29.56 %) |
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 131.70 | 330 | 43,461 | 14,884 | 15.2 K to 14.9 K (-2.17 %) |
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 131.20 | 260 | 34,112 | 15,214 | 15.5 K to 15.2 K (-1.68 %) |
Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 126.95 | 9 | 1,143 | 15,474 | 15.5 K to 15.5 K (-0.06 %) |
Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 125.69 | 1,036 | 130,215 | 15,483 | 16.5 K to 15.5 K (-6.27 %) |
Sep 09 2016 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 128.32 | 367 | 47,093 | 16,519 | 16.9 K to 16.5 K (-2.17 %) |
Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Option Exercise | A | 140.16 | 21,000 | 2,943,360 | 21,000 | |
Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 138.91 | 329 | 45,701 | 16,886 | 17.2 K to 16.9 K (-1.91 %) |
Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Grant | A | 0.00 | 3,000 | 0 | 17,215 | 14.2 K to 17.2 K (+21.10 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 141.23 | 328 | 46,323 | 14,215 | 14.5 K to 14.2 K (-2.26 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 142.17 | 200 | 28,434 | 14,543 | 14.7 K to 14.5 K (-1.36 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 143.46 | 182 | 26,110 | 14,743 | 14.9 K to 14.7 K (-1.22 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 144.40 | 141 | 20,360 | 14,925 | 15.1 K to 14.9 K (-0.94 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 145.43 | 200 | 29,086 | 15,066 | 15.3 K to 15.1 K (-1.31 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Grant | A | 0.00 | 8,802 | 0 | 15,266 | 6.5 K to 15.3 K (+136.17 %) |
Sep 10 2015 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Sell | S | 179.55 | 366 | 65,715 | 6,464 | 6.8 K to 6.5 K (-5.36 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Option Exercise | A | 180.37 | 18,300 | 3,300,771 | 18,300 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Grant | A | 0.00 | 3,830 | 0 | 6,830 | 3 K to 6.8 K (+127.67 %) |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Option Exercise | A | 164.16 | 25,000 | 4,104,000 | 25,000 | |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Page: 1